These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3094174)

  • 1. Treatment of gonorrhea with first- and second-generation cephalosporins and other new beta-lactam antibiotics.
    Mills J; Gottlieb A; Harrison WO
    Sex Transm Dis; 1986; 13(3 Suppl):203-6. PubMed ID: 3094174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of gonorrhoea--beta lactamase producers.
    Rajan VS
    Ann Acad Med Singap; 1983 Jan; 12(1):103-8. PubMed ID: 6222683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins.
    Tapsall JW
    Curr Opin Infect Dis; 2009 Feb; 22(1):87-91. PubMed ID: 19532086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of cephalosporins for gonorrhea: the impending problem of resistance.
    Barry PM; Klausner JD
    Expert Opin Pharmacother; 2009 Mar; 10(4):555-77. PubMed ID: 19284360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002.
    Commun Dis Intell Q Rep; 2003; 27(4):488-91. PubMed ID: 15508502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan.
    Muratani T; Akasaka S; Kobayashi T; Yamada Y; Inatomi H; Takahashi K; Matsumoto T
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3603-6. PubMed ID: 11709349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, 2004 to 2015: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation cephalosporins.
    Regnath T; Mertes T; Ignatius R
    Euro Surveill; 2016 Sep; 21(36):. PubMed ID: 27632642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global resistance of Neisseria gonorrhoeae: when theory becomes reality.
    Lewis DA
    Curr Opin Infect Dis; 2014 Feb; 27(1):62-7. PubMed ID: 24275696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of uncomplicated gonorrhea due to antibiotic-resistant Neisseria gonorrhoeae.
    Kraus SJ; Reynolds GH; Rolfs RT
    Sex Transm Dis; 1988; 15(4):234-43. PubMed ID: 3147528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the management of gonorrhea in adults in the United States.
    Newman LM; Moran JS; Workowski KA
    Clin Infect Dis; 2007 Apr; 44 Suppl 3():S84-101. PubMed ID: 17342672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of recent isolates of Neisseria gonorrhoeae to cephalosporins of different generations and penicillin G: a comparative evaluation.
    Korting HC
    Dermatologica; 1984; 168(2):67-72. PubMed ID: 6421633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonococcal infections: new methods of treatment.
    Lutz B
    Compr Ther; 1982 Jun; 8(6):47-52. PubMed ID: 6213356
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative in vitro activity of cefodizime, ceftazidime, aztreonam, and other selected antimicrobial agents against Neisseria gonorrhoeae.
    Khan MY; Gruninger RP; Nelson SM; Obaid SR
    Antimicrob Agents Chemother; 1983 Mar; 23(3):477-8. PubMed ID: 6303215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cefuroxime and penicillin in the treatment of uncomplicated gonorrhea.
    Lossick JG; Thompson SE; Smeltzer MP
    Antimicrob Agents Chemother; 1982 Sep; 22(3):409-13. PubMed ID: 6814355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonococcal infections and emergence of gonococcal decreased susceptibility to cephalosporins in France, 2001 to 2012.
    La Ruche G; Goubard A; Bercot B; Cambau E; Semaille C; Sednaoui P
    Euro Surveill; 2014 Aug; 19(34):. PubMed ID: 25188611
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin.
    Crider SR; Colby SD; Miller LK; Harrison WO; Kerbs SB; Berg SW
    N Engl J Med; 1984 Jul; 311(3):137-40. PubMed ID: 6234465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of uncomplicated infections due to Neisseria gonorrhoeae. A review of clinical efficacy and in vitro susceptibility studies from 1982 through 1985.
    Rice RJ; Thompson SE
    JAMA; 1986 Apr; 255(13):1739-46. PubMed ID: 3005679
    [No Abstract]   [Full Text] [Related]  

  • 19. The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting.
    Whiley DM; Goire N; Lahra MM; Donovan B; Limnios AE; Nissen MD; Sloots TP
    J Antimicrob Chemother; 2012 Sep; 67(9):2059-61. PubMed ID: 22604449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening for novel inhibitors of Neisseria gonorrhoeae penicillin-binding protein 2.
    Fedarovich A; Djordjevic KA; Swanson SM; Peterson YK; Nicholas RA; Davies C
    PLoS One; 2012; 7(9):e44918. PubMed ID: 23049763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.